Harvard Bioscience Cash Flow Statement (2010-2025) | HBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-0.67M	-0.41M	-0.17M	0.59M	-6.92M	2.44M	-3.40M	-1.67M	0.62M	-1.00M	-1.24M	-1.59M	-4.68M	-2.88M	-4.79M	0.33M	-50.34M	-2.28M	-1.23M	-3.37M
Depreciation and Depletion (Quarter)	0.45M	0.45M	0.42M	0.47M	0.38M	0.38M	0.36M	0.33M	0.33M	0.33M	0.42M	0.42M	0.40M	0.43M	0.44M	0.46M	0.45M	0.41M	0.42M	0.41M
Share-based Compensation (Quarter)	1.16M	1.16M	1.00M	1.03M	1.02M	1.24M	1.14M	1.01M	1.15M	0.10M	0.19M	1.38M	1.05M	0.13M	0.16M	0.96M	0.60M	0.10M	0.02M	0.46M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)	0.34M	0.54M	0.80M	1.17M		0.16M	0.40M	0.40M	0.13M	0.12M	0.12M	0.32M	0.03M	0.15M	0.15M	0.72M	0.25M	0.44M
Gains from Investment Securities (Quarter)	0.46M	0.07M	0.21M	-0.51M	-0.06M		0.23M	0.04M	0.16M	1.58M	0.11M	0.43M	0.01M	0.00M	0.01M	0.52M	0.00M	0.71M	0.66M	-0.05M
Asset Writedowns and Impairment (Quarter)
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)				5.55M				0.19M				1.84M	0.96M	0.09M
Cash from Operations (Quarter)	1.04M	0.77M	-0.66M	0.12M	-1.99M	-0.19M	0.65M	2.68M	1.81M	3.55M	4.36M	4.30M	1.40M	-0.85M	-0.84M	1.73M	2.99M	2.75M	1.08M	-0.10M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)																	48.00M
Amortizatization of Intangibles (Quarter)	1.46M	1.47M	1.46M	1.45M	1.47M	1.45M	1.57M	1.63M	1.39M	1.39M	1.36M	1.36M	1.38M	1.37M	1.38M	1.30M	1.20M	1.21M	0.90M	0.89M
Amortization of Deferred Charges (Quarter)	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.09M	0.10M	0.13M	0.21M	0.36M	0.62M
Depreciation & Amortization (CF) (Quarter)	0.45M	0.45M	0.42M	0.47M	0.38M	0.38M	0.36M	0.33M	0.33M	0.33M	0.42M	0.42M	0.40M	0.43M	0.44M	0.46M	0.45M	0.41M	0.42M	0.41M
Change in Working Capital
Change in Receivables (Quarter)	-0.58M	0.26M	1.05M	3.57M	-1.51M	-2.08M	-2.47M	1.28M	0.92M	-0.85M	-1.82M	0.94M	-0.70M	-2.75M	0.15M	2.33M	-1.44M	-1.79M	0.21M	3.96M
Change in Inventory (Quarter)	0.60M	1.92M	1.52M	1.81M	1.31M	1.36M	-2.34M	-0.58M	0.29M	-0.69M	0.23M	-1.35M	0.62M	1.13M	0.67M	-2.35M	-0.67M	-0.98M	-0.64M	-0.66M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	-0.70M	2.33M	-2.68M	-1.51M	-0.09M	-0.35M	-1.94M	1.88M	-0.15M	-0.12M	-0.03M	-0.23M	2.04M	-2.31M	-0.01M	-1.50M	1.47M	0.30M	-0.27M	0.80M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	-0.14M	0.04M	-0.04M	0.65M	-0.30M	0.55M	0.56M	-1.28M	0.74M	0.53M	-1.32M	-1.60M	0.30M	-0.80M	-0.32M	-0.82M	-0.03M	-0.38M	-0.02M	-1.10M
Investing Activities
Capital Expenditures (Quarter)	0.15M	0.21M	0.48M	0.36M	0.47M	0.44M	0.44M	0.23M	0.22M	0.52M	0.22M	0.83M	0.65M	0.82M	0.88M	0.30M	0.51M	0.09M	0.21M	0.45M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)	0.15M									0.11M	0.18M	0.23M	0.07M	0.15M	0.23M	0.17M	0.17M	0.14M	0.14M	0.15M
Acquisitions (Quarter)
Divestments (Quarter)									0.51M
Change in Acquisitions & Divestments (Quarter)													0.49M	1.40M	1.40M
Cash from Investing Activities (Quarter)	-0.30M	-0.21M	-0.48M	-0.36M	-0.47M	-0.44M	-0.44M	-0.23M	0.29M	-0.62M	-0.40M	-1.06M	-0.23M	0.46M	-1.11M	-0.47M	-0.68M	-0.23M	-0.35M	-0.60M
Financing Activities
Other financing activities (Quarter)	0.10M	0.53M	1.66M	0.86M		0.28M	0.39M	0.46M	0.16M	0.29M	-0.45M	2.52M	0.05M	0.01M	0.06M	0.10M	0.07M		0.02M	3.15M
Cash from Financing Activities (Quarter)	-3.14M	-0.19M	0.49M	2.59M	0.09M	-0.58M	0.38M	-2.73M	-2.89M	-2.38M	-2.75M	-4.12M	-1.05M	0.18M	2.10M	-1.36M	-1.20M	-1.26M	-1.28M	2.45M
Additional items
Exchange Rate Effect (Quarter)	-0.10M	0.05M	-0.04M	-0.08M	-0.03M	0.04M	0.30M	-0.35M	0.07M	-0.02M	-0.19M	-0.18M	-0.15M	0.00M	0.37M	-0.36M	0.34M	0.63M	-0.08M	0.04M
Change in Cash (Quarter)	-2.50M	0.42M	-0.69M	2.27M	-2.39M	-1.17M	0.89M	-0.64M	-0.72M	0.54M	1.02M	-1.06M	-0.03M	-0.21M	0.52M	-0.46M	1.44M	1.90M	-0.62M	1.80M
Free Cash Flow (Quarter)	0.89M	0.56M	-1.14M	-0.24M	-2.46M	-0.63M	0.21M	2.44M	1.59M	3.04M	4.14M	3.47M	0.76M	-1.66M	-1.72M	1.42M	2.47M	2.67M	0.88M	-0.55M
Net Cash Flow (Quarter)	-2.40M	0.37M	-0.65M	2.35M	-2.36M	-1.21M	0.58M	-0.29M	-0.79M	0.55M	1.21M	-0.87M	0.12M	-0.21M	0.15M	-0.10M	1.10M	1.26M	-0.54M	1.75M

Research Tools

Harvard Bioscience Cash Flow Statement (2010-2025) | HBIO

Create an account

Sign In

Reset Password